The global pulmonary drug delivery systems market size was valued at USD 60.11 Billion in 2025, driven by the increasing incidence of respiratory conditions across the globe. The market size is anticipated to grow at a CAGR of 5.65% during the forecast period of 2026-2035 to achieve a value of USD 104.15 Billion by 2035.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
5.65%
Value in USD Billion
2026-2035
*this image is indicative*
Pulmonary drug delivery systems are medical devices or drug formulations designed to deliver medications directly to the lungs through inhalation. These systems are used to treat various respiratory conditions, such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and respiratory infections, among others. Pulmonary drug delivery offers several advantages, including rapid onset of action, targeted drug delivery to the lungs, and reduced systemic side effects compared to oral or intravenous administration.
The growth of the market is driven by the strategic collaborations between pharma giants to resolve issues together resulting in increased market growth. For example, the strategic partnership between Hovione and H&T Presspart to develop the Sunriser© Capsule-based DPI platform is expected to address the evolving requirements of the pulmonary drug delivery systems market as they offer more efficient and adaptable solutions for inhalable medications. The development of the Sunriser© DPI is expected to result in more efficient and effective delivery of inhalable drugs resulting in enhanced patient compliance and outcomes for various respiratory conditions, such as asthma and chronic obstructive pulmonary disease (COPD).
The market growth is also driven by increased innovation, coupled with expanded product offerings, and improved drug delivery options for patients. Such collaborations are expected to influence the market greatly as they may result in patient-friendly, efficient, and adaptable inhalation solutions propelling the global pulmonary drug delivery systems market growth.
Pulmonary Drug Delivery Systems Market Report and Forecast 2026-2035 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Market Breakup by Applications
Market by End User
Market Breakup by Region
The global market for pulmonary drug delivery systems is experiencing significant growth driven by the increasing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. With these conditions continuing to affect a substantial portion of the global population, there is a growing demand for effective drug delivery systems specifically designed for pulmonary treatments in the market.
Additionally, advancements in inhalation technologies and drug formulations are also enhancing the efficiency and effectiveness of pulmonary drug delivery, further propelling the pulmonary drug delivery systems market growth.
Furthermore, the COVID-19 pandemic has highlighted the importance of respiratory health, leading to increased awareness and investments in pulmonary drug delivery systems. The need for efficient administration of respiratory medications, including vaccines and therapies for various lung infections is expected to further drive innovation and development of novel delivery devices in the market, propelling the market growth.
The increasing geriatric population, particularly in developed countries, is contributing to increased respiratory-related illnesses, further aiding the pulmonary drug delivery systems market demand. As healthcare systems focus on patient-centric care and improved treatment outcomes, the market is witnessing a surge in research and development activities, new product launches, and strategic collaborations. All these factors collectively are boosting the global market and are expected to drive the market in coming years as well.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 60.11 Billion in 2025, driven by increased awareness.
The market is anticipated to grow at a CAGR of 5.65% during the forecast period of 2026-2035 and is likely to reach a market value of USD 104.15 Billion by 2035.
The increasing prevalence of respiratory diseases is a major factor driving the market growth.
The market growth is driven by trends such as strategic collaborations between pharma giants to develop patient-centric solutions.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Various products in the market include dry powder inhalers, metered dose inhalers, and nebulizers, among others.
They find wide applications in cystic fibrosis, asthma, allergic rhinitis, and COPD, among others.
End users in the market are hospitals, diagnostic centres, and home care settings, among others.
Key players involved in the market are Koninklijke Philips NV, GlaxoSmithKline PLC, 3M, Novartis AG, Boehringer Ingelheim International GmbH, AstraZeneca, Cipla Inc., Merck & Co., GF Health Products Inc., Aerogen, PARI GmbH, and Gilbert Technologies.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share